SCHEDULE: Lytton, Lytton-Kambara Foundation Disclose Xtant Medical Stake

Laurence W. Lytton and the Lytton-Kambara Foundation have disclosed beneficial ownership of 5.5% and 5.0% respectively, in Xtant Medical Holdings, Inc. common stock.

Summary

• Laurence W. Lytton beneficially owns 7,702,002 shares of Xtant Medical Holdings, Inc. common stock, representing 5.5% of the outstanding class.
• The Lytton-Kambara Foundation beneficially owns 7,026,104 shares of Xtant Medical Holdings, Inc. common stock, representing 5.0% of the outstanding class.
• These percentages are calculated based on 140,004,240 shares of Common Stock outstanding on November 7, 2025, as reported in the Issuer's Form 10-Q for the quarterly period ended September 30, 2025.
• Laurence W. Lytton holds sole voting and dispositive power over 675,898 shares and shared voting and dispositive power over 7,026,104 shares.
• The Lytton-Kambara Foundation holds shared voting and dispositive power over 7,026,104 shares.
• The reporting persons certified that the securities were not acquired or held for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive disclosure, as it confirms significant investor interest without indicating any immediate control-related issues or negative developments. The passive nature of the investment, as certified, is generally well-received.

Positives

• Significant beneficial ownership by Laurence W. Lytton (5.5%) and the Lytton-Kambara Foundation (5.0%) indicates a notable investment in Xtant Medical Holdings, Inc.
• The certification that the holdings are not for control purposes suggests a passive investment, which can be viewed positively by current management and other shareholders.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the issuer's future performance or operations.

Management Comments

• The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

StockSavvy.ai notes that significant beneficial ownership disclosures, such as this Schedule 13G, are routine regulatory filings that provide transparency into major shareholder positions. While this filing does not offer direct insights into broader industry trends, it highlights the continued interest of certain investors in the medical technology sector, specifically in companies like Xtant Medical Holdings, Inc.

Corporate Governance

Related Party Transactions

• Laurence W. Lytton and the Lytton-Kambara Foundation have entered into an agreement for joint filing of SEC statements (Schedule 13D/13G and Forms 3, 4, or 5), with Laurence W. Lytton designated as the agent and attorney-in-fact for these filings.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant ownership stakes, potentially signaling confidence from major investors. The passive nature of the investment may reassure shareholders concerned about potential control battles.
• Management: The certification of non-control intent can alleviate concerns about activist pressure, allowing management to focus on strategic execution.

Key Dates

Keywords

Xtant Medical Holdings, XMHT, Schedule 13G, Beneficial Ownership, Laurence W. Lytton, Lytton-Kambara Foundation, Common Stock, SEC Filing, Institutional Ownership